Leiner OTC Sales Up 51% In FY 2000 With $33 Mil. From Granutec & Stanley
This article was originally published in The Tan Sheet
Executive Summary
Leiner Health Products' private label OTC drug sales rose 51% to $98.8 mil. in fiscal 2000, boosted by a $33 mil. net sales contribution from the Granutec and Stanley businesses.
You may also be interested in...
Leiner OTC Sales Buoy Company Performance As Supplement Market Slows
Leiner Health Products is committed to reinvigorating its struggling dietary supplement business despite the sluggish market atmosphere and the recent success of the company's growing OTC portfolio.
Leiner OTC Sales Buoy Company Performance As Supplement Market Slows
Leiner Health Products is committed to reinvigorating its struggling dietary supplement business despite the sluggish market atmosphere and the recent success of the company's growing OTC portfolio.
Leiner OTC Sales Buoy Company Performance As Supplement Market Slows
Leiner Health Products is committed to reinvigorating its struggling dietary supplement business despite the sluggish market atmosphere and the recent success of the company's growing OTC portfolio.